Malaria Information and Prophylaxis, by Country1 [S]
The information presented in this table is consistent with the information in the Health Information for International Travel 2010 (CDC's Yellow Book).
| Country | Areas with Malaria | Estimated relative risk of Malaria for US Travelers2 | Drug Resistance3 | Malaria Species4 | Recommended Chemoprophlaxis5 | Helpful links for Select Countries |
|---|---|---|---|---|---|---|
| Saint Barthelemy (France) | None | None | Not Applicable | Not Applicable | Not Applicable | |
| Saint Helena (U.K.) | None | None | Not Applicable | Not Applicable | Not Applicable | |
| Saint Kitts (Saint Christopher) and Nevis (U.K.) | None | None | Not Applicable | Not Applicable | Not Applicable | |
| Saint Lucia | None | None | Not Applicable | Not Applicable | Not Applicable | |
| Saint Martin (France) | None | None | Not Applicable | Not Applicable | Not Applicable | |
| Saint Pierre and Miquelon (France) | None | None | Not Applicable | Not Applicable | Not Applicable | |
| Saint Vincent and the Grenadines | None | None | Not Applicable | Not Applicable | Not Applicable | |
| Samoa (formerly Western Samoa) | None | None | Not Applicable | Not Applicable | Not Applicable | |
| San Marino | None | None | Not Applicable | Not Applicable | Not Applicable | |
| São Tomé and Príncipe | All | Very Low | Chloroquine | P. falciparum 85% P. malariae, P. ovale 15% P. vivax rare |
Atovaquone/ proguanil, doxycycline, or mefloquine | |
| Saudi Arabia | Present in emirates by border with Yemen, specifically Jizan and Asir. Transmission also in emirate of Al Bahah. None in cities of Jeddah, Mecca, Medina, Riyadh, and Ta'if. | Low | Chloroquine | P. falciparum predominantly P. vivax remainder |
Atovaquone/ proguanil, doxycycline, or mefloquine | Altitude information and to determine if a city is within a certain department Emirates of Saudi Arabia General map of Saudi Arabia |
| Senegal | All | High | Chloroquine | P. falciparum >85% P. ovale 5-10% P. vivax rare |
Atovaquone/ proguanil, doxycycline, or mefloquine | |
| Serbia | None | None | Not Applicable | Not Applicable | Not Applicable | |
| Seychelles | None | None | Not Applicable | Not Applicable | Not Applicable | |
| Sierra Leone | All | High | Chloroquine | P. falciparum 85% P. malariae, P. ovale, and P. vivax 15% |
Atovaquone/ proguanil, doxycycline, or mefloquine | |
| Singapore | None | None | Not Applicable | Not Applicable | Not Applicable | |
| Slovakia | None | None | Not Applicable | Not Applicable | Not Applicable | |
| Slovenia | None | None | Not Applicable | Not Applicable | Not Applicable | |
| Solomon Islands | All | High | Chloroquine | P. falciparum 60% P. vivax 35-40% P. ovale <1% |
Atovaquone/ proguanil, doxycycline, or mefloquine | |
| Somalia | All | No Data | Chloroquine | P. falciparum 95% P. vivax, P. malariae, and P. ovale 5% |
Atovaquone/ proguanil, doxycycline, or mefloquine | |
| South Africa | Present in the Mpumalanga Province, Limpopo (Northern) Province, and northeastern KwaZulu-Natal as far south as the Tugela River. Present in Kruger National Park. | Low | Chloroquine | P. falciparum 90% P. vivax 5% P. ovale 5% |
Atovaquone/ proguanil, doxycycline, or mefloquine | Municipalities of South Africa To determine if a city is within a certain province |
| Spain | None | None | Not Applicable | Not Applicable | Not Applicable | |
| Sri Lanka | All areas except none in the districts of Colombo, Galle, Gampaha, Kalutara, Matara, and Nuwara Eliya. | Very Low | Chloroquine | P. vivax 88% P. falciparum 12% |
Atovaquone/ proguanil, doxycycline, or mefloquine | Administrative divisions of Sri Lanka To determine if a city is within a certain province |
| Sudan | All | High | Chloroquine | P. falciparum 90% P. malariae, P. vivax, and P. ovale 10% |
Atovaquone/ proguanil, doxycycline, or mefloquine | |
| Suriname | Present in provinces of Sipaliwini and Brokopondo. None in Paramaribo. | Moderate | Chloroquine | P. falciparum 70% P. vivax 15-20% |
Atovaquone/ proguanil, doxycycline, or mefloquine | Map of Suriname |
| Swaziland | Present in eastern areas bordering Mozambique and South Africa including all of Lubombo district and the eastern half of Hhohho and Shiselweni districts. | Very Low | Chloroquine | P. falciparum 90% P. vivax 5% P. ovale 5% |
Atovaquone/ proguanil, doxycycline, or mefloquine | Administrative divisions of Swaziland To determine if a city is within a certain district |
| Sweden | None | None | Not Applicable | Not Applicable | Not Applicable | |
| Switzerland | None | None | Not Applicable | Not Applicable | Not Applicable | |
| Syria | None | None | Not Applicable | Not Applicable | Not Applicable | Map of Syria and surrounding countries Map of Governorates of Syria To determine if a city is within a certain governorate |
- The information presented herein was accurate at the time of publication; however, factors that can change rapidly and from year to year, such as local weather conditions, mosquito vector density, and prevalence of infection, can markedly affect local malaria transmission patterns. Updated information may be found on the CDC Travelers' Health website at www.cdc.gov/travel.
- This estimate of risk is based on numbers of cases of malaria reported in US travelers and the estimated volume of travel to these countries. In some instances the risk may be low because the actual intensity of transmission is low in that country. In other instances, significant malaria transmission may occur only in small focal areas of the country where US travelers seldom go. Thus even though the risk for the average traveler to that country may be low, the risk for the rare traveler going to the areas with higher transmission intensity will of course be higher. For some countries that are rarely visited by US travelers, there is insufficient information to make a risk estimate.
- Refers to P. falciparum malaria unless otherwise noted.
- Estimates of malaria species are based on best available data from multiple sources.
- Several medications are available for chemoprophylaxis. When deciding which drug to use, consider specific itinerary, length of trip, cost of drug, previous adverse reactions to antimalarials, drug allergies, and current medical history. All travelers should seek medical attention in the event of fever during or after return from travel to areas with malaria.
- This risk estimate is based largely on cases occurring in US military personnel who travel for extended periods of time with unique itineraries that likely do not reflect the risk for the average US traveler.
- Primaquine can cause hemolytic anemia in persons with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Patients must be screened for G6PD deficiency prior to starting primaquine.
